Products

Penile Prosthesis Implantation System

Bryant Bionics seeks to advance penile prosthesis devices and surgical techniques to encompass all that is state of the art.

This includes:

a true “no-touch” solution to decrease infections,
real-time image guidance for 100% confirmation of implant placement,
further advancement of minimally invasive urologic surgery techniques,
a system designed to meet the needs of next-generation prosthesis mechanics and materials, and
overall decreased healthcare costs due to reduced risk of infection and re-operation/revision.

Problem Overview

Erectile dysfunction affects nearly 20% of men 20 years of age and older and over 50% of men with diabetes. Almost 1/5^th of men report no improvement with medications. Overall, treatment satisfaction is only 40% with penile injections and 51% with oral medications. However, while over 90% of men report satisfaction with the use of penile implants, less than 5% of men eligible for a penile prosthesis undergo the procedure. Cost, surgical anxiety, device malfunction, and surgical risks (infection and re-operation) are primary deterrents.

The Solution

Bryan Bionics’ patent-pending penile prosthesis implantation system includes both methods and device modifications allowing for real-time image guidance in prosthesis implantation to reduce the risk of cross-over and urethral injury, confirming the position of the prosthesis, optimize erection length, and decrease surgical anxiety via interventional and minimally invasive surgical methods. Further, our methods and device modifications allow for a true “no-touch” solution in order to decrease infection and re-operation rates. This also reduces the risk of fibrosis and associated deformity and erection shortening.

Our novel methods and devices are poised for easy adoption of next-generation implants and materials allowing our IP to be readily applied to any new technology.

Video Demonstration

Download Brochure

Current Prosthesis Risks Adressed

Risks associated with penile prothesis include penile shortening, infection (1-3%), device perforation or erosion (1-11%), malfunction (5-20% failure at 5 years), and SST deformity (1-10%). Revision costs associated with prosthesis infections are 6-fold greater than the implantation cost. Further, scarring and fibrosis from the initial implantation can lead to decreased erectile length/girth as well as difficult revision surgery.